333 related articles for article (PubMed ID: 23773390)
1. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Liu J; Li J; Zhu K; Zheng X; Chen M; Chen M; Liao Z
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):671-7. PubMed ID: 23773390
[TBL] [Abstract][Full Text] [Related]
2. [Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].
Lin Y; Chen J; Li J; Liu J; Zhu K; Pan C; Chen M; Pan J
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):151-4. PubMed ID: 24796467
[TBL] [Abstract][Full Text] [Related]
3. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
5. [A prospective comparison between surgery alone and postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma].
Cao XF; Lü J; Zhu B; An HY; Wang S; Wu BC; Ji L; Tao L; Wang DD
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):452-5. PubMed ID: 20819489
[TBL] [Abstract][Full Text] [Related]
6. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
[TBL] [Abstract][Full Text] [Related]
9. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
[TBL] [Abstract][Full Text] [Related]
10. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
12. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
13. Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
Higuchi K; Komori S; Tanabe S; Katada C; Azuma M; Ishiyama H; Sasaki T; Ishido K; Katada N; Hayakawa K; Koizumi W;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):872-9. PubMed ID: 24867539
[TBL] [Abstract][Full Text] [Related]
14. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy.
Park JW; Kim JH; Choi EK; Lee SW; Yoon SM; Song SY; Lee YS; Kim SB; Park SI; Ahn SD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):691-7. PubMed ID: 20888705
[TBL] [Abstract][Full Text] [Related]
17. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
Lu JC; Kong C; Tao H
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
[TBL] [Abstract][Full Text] [Related]
19. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
